Cargando…
Predictive Value of Circulating Tumor Cells Detected by ISET(®) in Patients with Non-Metastatic Prostate Cancer Undergoing Radical Prostatectomy
There is an unmet need for reliable biomarkers to predict prostate cancer recurrence after prostatectomy in order to better guide the choice of surgical treatment. We have evaluated the predictive value of the preoperative detection of Circulating Tumor Cells (CTC) for prostate cancer recurrence aft...
Autores principales: | Garrido Castillo, Laura Nalleli, Mejean, Arnaud, Vielh, Philippe, Anract, Julien, Decina, Alessandra, Nalpas, Bertrand, Benali-Furet, Naoual, Desitter, Isabelle, Paterlini-Bréchot, Patrizia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877346/ https://www.ncbi.nlm.nih.gov/pubmed/35207452 http://dx.doi.org/10.3390/life12020165 |
Ejemplares similares
-
Polyploid Giant Cancer Cells Are Frequently Found in the Urine of Prostate Cancer Patients
por: Garrido Castillo, Laura Nalleli, et al.
Publicado: (2023) -
Circulating cancer giant cells with unique characteristics frequently found in patients with myelodysplastic syndromes (MDS)
por: Ali, Abdullah Mahmood, et al.
Publicado: (2023) -
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
por: Farace, F, et al.
Publicado: (2011) -
Circulating Tumor Cells: Who is the Killer?
por: Paterlini-Bréchot, Patrizia
Publicado: (2014) -
Circulating Tumor Cells for the Management of Renal Cell Carcinoma
por: Broncy, Lucile, et al.
Publicado: (2018)